Identifikatu
Taldeak
Ikertzaileak
Emaitzak
Ciencias Económicas y Empresariales
Fakultatea
The Third Affiliated Hospital of Harbin Medical University
Harbin, China
Hemen zaude
Lankidetzak
The Third Affiliated Hospital of Harbin Medical University
The Third Affiliated Hospital of Harbin Medical University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de